Posts

Blog Post

Momenta Pharmaceuticals Announces Positive Results from Phase 2 Vivacity-MG Study of Nipocalimab for Treatment of Generalized Myasthenia Gravis

By Sujatha Gurunathan | June 18, 2020
Blog Post

Hacking COVID: MDA Staff Edition

By MDA Staff | June 18, 2020
Blog Post

Hacking COVID: MDA Ambassador Edition, Part 2

By MDA Staff | June 16, 2020
Dr. Stephan Züchner
Blog Post

Five Questions With CMT Researcher Stephan Züchner

By MDA Staff | June 12, 2020
Blog Post

Sarepta Therapeutics Announces Positive Results from the SRP-9003 Gene Therapy Trial to Treat LGMD2E

By Sujatha Gurunathan | June 11, 2020
Blog Post

Hacking COVID: MDA Ambassador Edition, Part 1

By MDA Staff | June 11, 2020
Blog Post

Hacking COVID: Voices from the Community, Part 3

By MDA Staff | June 9, 2020
Blog Post

ReveraGen BioPharma Announces Completion of Vamorolone Study in 41 DMD Patients

By Sujatha Gurunathan | June 8, 2020
Blog Post

MDA Summer Camp’s New Adventure: Going Virtual

By Lindsey Baker | June 8, 2020
Blog Post

A Letter from Case Worker Jana Unislawski to the MDA Community: How to Create an Emergency Care Plan for the COVID-19 Era

By Jana Unislawski | June 5, 2020